Reduced Function of the Adaptor SH2B3 Promotes T1D via Altered Cytokine-Regulated, T-Cell–Intrinsic Immune Tolerance
Authors:
- Taylor K. WatsonTWTaylor K. Watson
- Aaron B.I. RosenARAaron B.I. Rosen
- Travis DrowTDTravis Drow
- Jacob A. MedjoJMJacob A. Medjo
- Yan GeYGYan Ge
- H. Denny LiggittHLH. Denny Liggitt
- Kimberly A. Dill-McFarlandKDKimberly A. Dill-McFarland
- Matthew C. AltmanMAMatthew C. Altman
- Patrick J. ConcannonPCPatrick J. Concannon
- Jane H. BucknerJBJane H. Buckner
- 6 March 2025
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 74 (6) , 943-955
Abstract
Genome-wide association studies have identified SH2B3 as an important non-MHC gene for islet autoimmunity and type 1 diabetes (T1D). In this study, we found a single SH2B3 haplotype significantly associated with increased risk for human T1D. Fine mapping has demonstrated the most credible causative variant is the single nucleotide rs3184504*T polymorphism in SH2B3. To better characterize the role of SH2B3 in T1D, we used mouse modeling and found a T-cell–intrinsic role for SH2B3 regulating peripheral tolerance. SH2B3 deficiency had minimal effect on T-cell receptor (TCR) signaling or proliferation across antigen doses, yet enhanced cell survival and cytokine signaling including common γ-chain–dependent and interferon-γ receptor signaling. SH2B3-deficient naive CD8+ T cells showed augmented STAT5-MYC and effector-related gene expression partially reversed with blocking autocrine IL-2 in culture. Using the rat insulin promoter–membrane-bound ovalbumin (RIP-mOVA) model, we found CD8+ T cells lacking SH2B3 promoted early islet destruction and diabetes without requiring CD4+ T cell help. SH2B3-deficient cells demonstrated increased survival and reduced activation-induced cell death. Lastly, we created a spontaneous NOD.Sh2b3−/− mouse model and found markedly increased incidence and accelerated T1D across sexes. Collectively, these studies identify SH2B3 as a critical mediator of peripheral T-cell tolerance limiting the T-cell response to self-antigens. Article Highlights: The rs3184504*T polymorphism, encoding a hypomorphic variant of the negative regulator SH2B3, strongly associates with type 1 diabetes. SH2B3 deficiency results in hypersensitivity to cytokines, including IL-2 and IFN-γ, in murine CD4+ and CD8+ T cells, particularly postactivation. SH2B3-deficient CD8+ T cells exhibit a transcriptome comparable to wild-type CD8+ T cells at baseline, but, upon antigen stimulation, SH2B3-deficient cells upregulate genes characteristic of enhanced JAK-STAT signaling and effector functions. T-cell–intrinsic SH2B3 deficiency results in severe islet destruction in an adoptive transfer murine type 1 diabetes model, whereas global SH2B3 deficiency accelerates spontaneous NOD diabetes across sexes.Keywords
All Related Versions
Funding Information
- National Institute of Diabetes and Digestive and Kidney Diseases (DP3DK111802, K08DK114568, R03DK134746)
This publication has 48 references indexed in Scilit:
- The CD8+ T cell tolerance checkpoint triggers a distinct differentiation state defined by protein translation defectsImmunity, 2024
- Interleukin-2 signaling in the regulation of T cell biology in autoimmunity and cancerImmunity, 2024
- Type 1 diabetes in diverse ancestries and the use of genetic risk scoresThe Lancet Diabetes & Endocrinology, 2022
- RNA-Seq Signatures Normalized by mRNA Abundance Allow Absolute Deconvolution of Human Immune Cell TypesCell Reports, 2019
- BioJupies: Automated Generation of Interactive Notebooks for RNA-Seq Data Analysis in the CloudCell Systems, 2018
- Impact of Genetic Polymorphisms on Human Immune Cell Gene ExpressionCell, 2018
- The importance of the Non Obese Diabetic (NOD) mouse model in autoimmune diabetesJournal of Autoimmunity, 2016
- Lnk prevents inflammatory CD8+ T‐cell proliferation and contributes to intestinal homeostasisEuropean Journal of Immunology, 2014
- Interleukin-2 and Inflammation Induce Distinct Transcriptional Programs that Promote the Differentiation of Effector Cytolytic T CellsImmunity, 2010
- Control of B Cell Production by the Adaptor Protein LnkImmunity, 2000